Pfizer Inc.
PFE
$23.97
$0.100.42%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 402.20% | 2,651.13% | 279.00% | -59.44% | -112.08% |
| Total Depreciation and Amortization | -22.92% | 5.44% | 11.76% | 12.71% | 16.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.77% | -62.86% | -68.54% | -163.66% | 432.39% |
| Change in Net Operating Assets | 396.32% | -164,800.00% | -41.16% | 130.05% | 103.29% |
| Cash from Operations | 97.00% | 63.08% | 46.48% | -6.47% | -45.02% |
| Capital Expenditure | 33.27% | 20.25% | 25.54% | 21.43% | 17.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -158.41% | -158.41% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.97% | -46.61% | -63.07% | 889.51% | 757.31% |
| Cash from Investing | 89.25% | 112.39% | 108.22% | 73.84% | 86.12% |
| Total Debt Issued | -78.83% | -81.21% | -76.88% | -47.14% | -55.00% |
| Total Debt Repaid | -8.32% | -151.40% | -524.65% | -172.81% | -34.51% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 23.28% | -2.80% | -2.87% | -2.94% | -3.00% |
| Other Financing Activities | 25.40% | 24.57% | 25.79% | 22.08% | 10.80% |
| Cash from Financing | -161.52% | -172.94% | -165.76% | -142.18% | -142.03% |
| Foreign Exchange rate Adjustments | 65.82% | 31.82% | -65.00% | 41.54% | 24.76% |
| Miscellaneous Cash Flow Adjustments | -166.67% | -200.00% | -100.00% | -- | 250.00% |
| Net Change in Cash | 122.74% | 148.61% | -173.91% | -209.82% | -280.30% |